• 1
    Taylor DC. Psychiatric and social issues in measuring the input and output of epilepsy surgery. In: EngelJJr, ed. Surgical treatment of the epilepsies Raven Press: New York , 1987:485503.
  • 2
    Hermann BP. Quality of life in epilepsy. J Epilepsy 1992;5:15365.
  • 3
    Hermann BP, Whitman S. neurobiological, psychosocial and pharmacological factors underlying interictal psychopathology in epilepsy. In: SmithDB, TreimanDM, TrimbleMR, eds. Neurobehavioral problems in epilepsy New York : Raven Press, 1991:43952. (Advances in neurology; vol. 55.).
  • 4
    Begley CE, Annegers JF, Lairson DR, Reynolds TF, Hauser WA. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:123043.
  • 5
    Engel J Jr. Surgery for seizures. N Engl J Med 1996;334:64752.
  • 6
    Surgery for epilepsy. National Institutes of Health. Consensus conference: surgery for epilepsy. JAMA 1990;264:72933. March 19–21, 1990;8:10.
  • 7
    Nakasato N, Levesque MR, Babb TL. Seizures outcome following standard temporal lobectomy: correlation with hippocampal neuron loss and extrahippocampal pathology. J Neurosurg 1992;77:194200.
  • 8
    Guldvog B, Loyning Y, Hauglie-Hansen E, Flood S, Bjornaes H. Surgical versus medical treatment for epilepsy. I. Outcome related to survival, seizures and neurologic deficit. Epilepsia 1991;32: 37588.
  • 9
    Wieser HG. Selective amygdalo-hippocampectomy for temporal lobe epilepsy. Epilepsia 1988; 29(suppl 2):S10013.
  • 10
    Rasmussen T, Feindel W. Temporal lobectomy: review of 100 cases with major hippocampectomy. Can J Neurol Sci 1991;18:6012.
  • 11
    Davies KG, Weeks RD. Temporal lobectomy for intractable epilepsy: experience with 58 cases over 21 years. Br J Neurosurg 1993;7:2333.
  • 12
    Pokey CE, Scarano P. The drability of the result of anterior temporal lobectomy for epiled J Neurosurg Sci 1993;37:1418.
  • 13
    Haglund MM, Ojemann LM. Seizure outcome in patients undergoing temporal lobe resections for epilepsy. Neurosurg Clin North Am 1993;4:33744.
  • 14
    Tartara A, Manni R, Galimberti CA, Hardenberg J, Orwin J, Perucca E. Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study. Epilepsia 1986;27:71723.
  • 15
    Ring HA, Heller AJ, Farr IN, Reynolds EH. Vigabatrin: rational treatment for chronic epilepsy. J Neurol Neurosurg Psychiatry 1990;53:10515.
  • 16
    Schmidt D. Two antiepileptic drugs for intractable epilepsy with complex-partial seizures. J Neurol Neurosurg Psychiatry 1982 45:111924.
  • 17
    Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313:14551.
  • 18
    The U. S. Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:22928.
  • 19
    Vickrey BG, Hays RD, Rausch R, et al. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet 1995;346:14459.
  • 20
    Vickrey BG, Hays RD, Graber J, Rausch R, Engel J Jr, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992;30:299319.
  • 21
    Hermann BP, Wyler AR, Ackerman B, Rosenthal TL. Short–term psychological outcome of anterior temporal lobectomy. J Neurosurg 1987:1:32734.
  • 22
    Langfitt JT. Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy. Qua1 Life Res 1995;4:10114.
  • 23
    Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996;37:14861.
  • 24
    Kriedel T. Cost-benefit of epilepsy clinics. Soc Sci Med 1980;14C:359.
  • 25
    Wiebe S, Gafni A, Blume WT, Girvin JP. An economic evaluation of surgery for temporal lobe epilepsy. J Epilepsy 1995;8:22735.
  • 26
    Redelmeier DA, Fuchs VR. Hospital expenditures in the United States and Canada [Comments]. N Engl J Med 1993;328:7728.
  • 27
    Woolhandler S, Himmelstein DU. The deteriorating administrative efficiency of the U.S. health care system [Comments] [published erratm appears in N Engl J Med 1994; 331:336]. N Engl J Med 1991;324:12538.
  • 28
    Engel J Jr. Outcome with respect to epileptic seizures. In: EngelJJr ed. Surgical treatment of the epilepsies New York Raven Press, 1987:55372.
  • 29
    Lüders HO. Epilepsy surgery, 1st ed. New York Raven Press, 1992.
  • 30
    Engel J Jr. Surgical treatment of the epilepsies, 2nd ed. New York Raven Press, 1993.
  • 31
    Pilcher WH, Roberts DW, Flanigan HF, et al. Complications of epilepsy surgery. In: EngelJJr, ed. Surgical treament of the epilepsies, 2nd ed. New York Raven Press, 1993:56581.
  • 32
    Finkler SA. The distinction between costs and charges. Ann Intern Med 1982 96:1029.
  • 33
    Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593600.
  • 34
    Hauser WA. Mortality in patients with epilepsy. Epilepsia 1980;21:399412.
  • 35
    Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the “DELE”). II. Use in medical decision making. Am J Med 1982;73:88997.
  • 36
    Vickrey BG, Hays RD, Spritzer KL. Methodological issues in quality of life assessment for epilepsy surgery. In: ChadwickDW, BakerGA, JacobyA, eds. Quality of life and quality of care in epilepsy: update 1993. London : Royal Society of Medicine Services Limited Round Table Series 31, 1993:2737.
  • 37
    Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes New York Oxford University Press, 1987.
  • 38
    Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:71621.
  • 39
    Sutula TP, Sackellares JC, Miller JQ. Dreifuss FE. Efficacy of intensive monitoring and prolonged hospitalization in refractory epilepsy. Trans Am Neurol Assoc 1979;104:2147.
  • 40
    Mason J, Drummond MF, Torrance GW. Some guidelines on the use of cost effectiveness league tables. Br Med J 1993;302:5702.
  • 41
    Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. Working paper series–Nat1 Bureau Econ Res 1992;4164:134.
  • 42
    King JT Jr, Glick, HA, Mason TJ, Flamm Es. Elective surgery for asymptomatic, unruptured, intracranial aneurysms; a cost–effectiveness analysis. J Neurosug 1995;83:40312.
  • 43
    Lüders HO, Engel J Jr, Munari C. General principles. In: EngelJJr, ed. Surgical treatment of the epilepsies, 2nd ed. New York Raven Press, 1993:13753.
  • 44
    U.S. Bureau of the Census. Statistical abstracts of the United States: 1995, 115th ed. Washington , D.C. : 1995.
  • 45
    Lansky SB, Caims NA, Clark GM. Childhood cancer: non-medical costs of the illness. Cancer 1979;43:4038.
  • 46
    Drummond M, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care: practice, problems and potential. Int J Tech Assess Health Care 1993;9:2636.
  • 47
    Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;123:6170.
  • 48
    Walczak TS, Radtke RA, McNamara JO, et al. Anterior temporal lobectomy for complex partial seizures: evaluation, results, and long-term follow-up in 100 cases. Neurology 1990;40:4138.
  • 49
    Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:32238.
  • 50
    Homberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients well-being and consequent effect on a cost-effectiveness analysis. J CIin Epidemiol 1996;45:50512.
  • 51
    Nord E. Methods for quality adjustment of life years. SOC Sci Med 1992;34:55969.
  • 52
    Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis 1978;31:697704.
  • 53
    Mittan RJ. Fear of seizures. In: WhitmanS, HermannBP, eds. Psychopathology in epilepsy: social dimensions New York Oxford University Press, 1986:90121.
  • 54
    Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992 146:47381.
  • 55
    O'Neill BP, Ladon B, Harris LM, Riley HL, Dreifuss FE. A comprehensive, interdisciplinary approach to the care of the institutionalized person with epilepsy. Epilepsia 1977;18:24350.
  • 56
    Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:31222.
  • 57
    Sperling MR, O'Connor MJ, Saykin AJ, et al. A noninvasive protocol for anterior temporal lobectomy. Neurology 1992;42:41621.
  • 58
    Ribaric II. Why are so few patients operated on for epilepsy? A Yugoslavian perspective. Acta Neurochir [Suppl] 1990;50:10716.
  • 59
    Binnie CD, Elwes RDC, Polkey CE, Volans A. Utility of stereo-electroencephalography in preoperative assessment of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1994;57:5865.
  • 60
    Rasmussen TB. Surgical treatment of complex partial seizures: results, lesson, and problems. Epilepsia 1983; 24(suppl 1):S6576.
  • 61
    Schechter CB, Rose DN, Fahs MC, Silver AL. Tuberculin screening: cost-effectiveness analysis of various testing schedules. Am J Prev Med 1990;6:16775.
  • 62
    Tosteson AN, Rosenthal DI, Melton LJ, III, Weinstein MC. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med 1990;113:594603.
  • 63
    Simon DG, Lubin MF. Cost-effectiveness of computerized tomography and magnetic resonance imaging in dementia. Med Decis Making 1985;5:33552.
  • 64
    Hillner BE, Smith TJ, Desch CE. Efficacy and cost–effectiveness of autologous bone marrow transplantation in metastatic breast cancer. JAMA 1992;267:2@5560.
  • 65
    Cohen DJ, Breall JA, Ho KKL, et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Circulation 1989:185974.
  • 66
    Tsevat J, Durand-Zaleski I, Pauker S. Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. Am J Public Health 1989;79:73943.
  • 67
    Katz DA, Cronenwett JL. The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms. J Vasc Surg 1994; 1998091.
  • 68
    Mandelblatt JS, Fahs MC. The cost-effectiveness of cervical cancer screening for low-income elderly women. JAMA 1988;259:240913.